News tagged with pharmaceutical
Researchers link stress and pancreatic cancer in new paper
Pancreatic cancer is a deadly disease with increased incidences in the recent years. According to NDSU researchers, epidemiological data show chronic stress in a negative social and psychological state such as depression ...
Cancer
Feb 15, 2013 |
5 / 5 (3) |
0
Researchers find new clue to clinical trial failures of MMP cancer therapies
Proposed cancer therapeutic drugs based on blocking the catalytic activities of matrix metalloproteinases (MMPs), which profoundly remodel the environment surrounding a breast cell, have performed poorly ...
Cancer
Feb 12, 2013 |
not rated yet |
0
New hope for dementia sufferers
(Medical Xpress)—Research that aims to rid dementia sufferers' brains of toxins could lead to a new treatment that reverses the symptoms of Alzheimer's disease in the future.
Alzheimer's disease & dementia
Feb 08, 2013 |
not rated yet |
0
Rivaroxaban found noninferior to enoxaparin in acutely ill
(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Study: Ritalin treats apathy in patients with Alzheimer's disease
Leslye Nathe did not realize the profound effect that Ritalin was having on her mother's Alzheimer's disease until a doctor stopped the prescription.
Alzheimer's disease & dementia
Feb 05, 2013 |
4 / 5 (2) |
0
KaloBios Pharma edges higher following IPO
(AP)—Shares of respiratory drug maker KaloBios Pharmaceuticals are inching higher on the first day of trading.
Other
Feb 01, 2013 |
not rated yet |
0
Medical school gift restriction policies linked to subsequent prescribing behavior
Doctors who graduate from medical schools with an active policy on restricting gifts from the pharmaceutical industry are less likely to prescribe new drugs over existing alternatives, suggests a study published in BMJ today. ...
Medications
Jan 31, 2013 |
not rated yet |
0
New target for treating wide spectrum of cancers
(Medical Xpress)—UC Irvine biologists, chemists and computer scientists have identified an elusive pocket on the surface of the p53 protein that can be targeted by cancer-fighting drugs. The finding heralds a new treatment ...
Cancer
Jan 31, 2013 |
not rated yet |
0
|
Danish Novo Nordisk profit surges
Danish pharmaceutical company Novo Nordisk A/S on Thursday reported a 23 percent growth in fourth-quarter net profit on strong sales of diabetic drugs and gave a positive outlook as regulators worldwide begin to approve its ...
Other
Jan 31, 2013 |
not rated yet |
0
Silibinin, found in milk thistle, protects against UV-induced skin cancer
A pair of University of Colorado Cancer Center studies published this month show that the milk thistle extract, silibinin, kills skin cells mutated by UVA radiation and protects against damage by UVB radiation – thus protecting ...
Cancer
Jan 30, 2013 |
4 / 5 (2) |
0
|
Linagliptin: Once again, no proof of added benefit
Linagliptin (trade name Trajenta) has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market ...
Medications
Jan 30, 2013 |
not rated yet |
0
Perampanel for epilepsy: No proof of added benefit
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according ...
Medications
Jan 30, 2013 |
not rated yet |
0
Greater transparency needed in publishing information from clinical trials
An initiative from the drugs regulator, the European Medicines Agency, to commit to releasing all of the information from clinical trials once the marketing authorization process has ended, which has been greeted with cautious ...
Other
Jan 29, 2013 |
not rated yet |
0
Discrepant analyses of industry-sponsored clinical trials
Discrepancies between internal and published analyses of industry-sponsored clinical trials lead to further calls for transparency
Other
Jan 29, 2013 |
not rated yet |
0
In CAD, highest mortality risk for central obesity, normal BMI
(HealthDay)—For individuals with coronary artery disease (CAD), central obesity in combination with normal weight is associated with the highest risk of mortality, according to research published in the ...
Overweight and Obesity
Jan 29, 2013 |
not rated yet |
0
